Benvenuto nella sezione online di

La Pediatria di Netter, 2ª ed.

Letture Consigliate

Sezione IV

Allergologia e Immunologia

Terri Brown-Whitehorn︎

Lillian Jin, Katie Kennedy e Terri Brown-Whitehorn

  • Dreskin S.K, Stitt J.M. Anaphylaxis. In: Burks A.W, Holgate S.T, O’Hehir R.E, et al., eds. Middleton’s Allergy: Principles & Practice . 9th ed. 2020:1228–1246.
  • Lee J, Rodio B, Lavelle J, et al. Improving anaphylaxis care: the impact of a clinical pathway. Pediatrics . 2018;141(5):e20171616.
  • Nunez J, Santillanes G. Anaphylaxis in pediatric patients: early recognition and treatment are critical for best outcomes. Pediatr Emerg Med Pract . 2019;16(6):1–24.
  • Reber L.L, Hernandez J.D, Galli S.J. The pathophysiology of anaphylaxis. J Allergy Clin Immunol . 2017;140(2):335–348.
  • Shaker M.S, Wallace D.V, Golden D.B.K, et al. Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol . 2020;145(4):1082–1123. doi: 10.1016/j.jaci.2020.01.017.
  • Sicherer S.H, Simons F.E.R. Epinephrine for first-aid management of anaphylaxis. Pediatrics . 2017;139(3):e20164006.

Whitney Reid Fink e Laura Gober

  • Ben-Shoshan M, Grattan C.E. Management of pediatric urticaria with review of the literature on chronic spontaneous urticaria in children. J Allergy Clin Immunol Pract . 2018;6(4):1152–1161. doi: 10.1016/j.jaip.2018.02.015.
  • Brodell L.A, Beck L.A. Differential diagnosis of chronic urticaria. Ann Allergy Asthma Immunol . 2008;100:181–188.
  • Büyüköztürk S, Gelincik A, Demirtürk M, Kocaturk E, Colakoğlu B, Dal M. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey. J Dermatol . 2012;39(5):439–442. doi: 10.1111/j.1346-8138.2011.01473.x.
  • Pier J, Bingemann T.A. Urticaria, angioedema, and anaphylaxis. Pediatr Rev . 2020;41(6):283–292. doi: 10.1542/pir.2019-0056.
  • Radonjic-Hoesli S, Hofmeier K.S, Micaletto S, Schmid-Grendelmeier P, Bircher A, Simon D. Urticaria and angioedema: an update on classification and pathogenesis. Clin Rev Allergy Immunol . 2018;54(1):88–101. doi: 10.1007/s12016-017-8628-1.
  • Weinberger M. Treating chronic spontaneous urticaria in children. J Allergy Clin Immunol Pract . 2018;6(5):1806. doi: 10.1016/j.jaip.2018.05.003.

Stanislaw J. Gabryszewski e Rahul Datta

  • Chan S.K. Advances in aeroallergen immunotherapy. Curr Opin Pediatr . 2019;31(6):828–834.
  • Corren J, et al. Allergic and nonallergic rhinitis. In: Adkinson N.F, et al., ed. Middleton’s Allergy: Principles and Practice . 8th ed. Philadelphia, PA: Elsevier Saunders; 2014 (chap 42).
  • Hill D.A, Spergel J.M. The atopic march: critical evidence and clinical relevance. Annal Allergy Asthma Immunol . 2018;120(2):131–137.
  • Kakli H.A, Riley T.D. “Allergic rhinitis.” Primary care. Clin Office Pract . 2016;43(3):465–475.
  • Shinee T, Sutikno B, Abdullah B. The use of biologics in children with allergic rhinitis and chronic rhinosinusitis: current updates. Pediatr Invest . 2019;3(3):165–172.
  • Wise S.K, Lin S.Y, Toskala S. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol . 2018;8(2):108–352.

Aaron L. Bodansky e Soma C. Jyonouchi

  • Abbott J.K, Gelfand E.W. Common variable immunodeficiency: diagnosis, management, and treatment. Immunol Allergy Clin North Am . 2015;35(4):637–658. doi: 10.1016/j.iac.2015.07.009.
  • Adrovic A, Sahin S, Barut K, Kasapcopur O. Familial Mediterranean fever and Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis (PFAPA) syndrome: shared features and main differences. Rheumatol Int . 2019;39(1):29–36. doi: 10.1007/s00296-018-4105-2.
  • Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol . 2017;36(8):1707–1713. doi: 10.1007/s10067-017-3715-5.
  • Al-Shaikhly T, Ochs H.D. Hyper IgE syndromes: clinical and molecular characteristics. Immunol Cell Biol . 2019;97(4):368–379. doi: 10.1111/imcb.12209.
  • Arnold D.E, Heimall J.R. A review of chronic granulomatous disease. Adv Ther . 2017;34(12):2543–2557. doi: 10.1007/s12325-017-0636-2.
  • Bousfiha A, Jeddane L, Al-Herz W, et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol . 2015;35(8):727–738. doi: 10.1007/s10875-015-0198-5.
  • Bousfiha A, Jeddane L, Picard C, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol . 2018;38(1):129–143. doi: 10.1007/s10875-017-0465-8.
  • d’Hennezel E, Bin Dhuban K, Torgerson T, Piccirillo C.A. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome [published correction appears in J Med Genet. 2012;49(12):784. Piccirillo, Ciriaco [corrected to Piccirillo, Ciriaco A]]. J Med Genet . 2012;49(5):291–302. doi: 10.1136/jmedgenet-2012-100759.
  • Dorsey M.J, Puck J.M. Newborn screening for severe combined immunodeficiency in the United States: lessons learned. Immunol Allergy Clin North Am . 2019;39(1):1–11. doi: 10.1016/j.iac.2018.08.002.
  • Dvorak C.C, Haddad E, Buckley R.H, et al. The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). J Allergy Clin Immunol . 2019;143(1):405–407. doi: 10.1016/j.jaci.2018.08.027.
  • Freeman A.F, Holland S.M. Clinical manifestations of hyper IgE syndromes. Dis Markers . 2010;29(3-4):123–130. doi: 10.3233/DMA-2010-0734.
  • Garrison M.M, Jeffries H, Christakis D.A. Risk of death for children with down syndrome and sepsis. J Pediatr . 2005;147:748–752. doi: 10.1016/j.jpeds.2005.06.032.
  • Huggard D, Doherty D.G, Molloy E.J. Immune dysregulation in children with down syndrome. Front Pediatr . 2020;8:73. doi: 10.3389/fped.2020.00073.
  • Joshi A.Y, Abraham R.S, Snyder M.R, Boyce T.G. Immune evaluation and vaccine responses in down syndrome: evidence of immunodeficiency? Vaccine . 2011;29:5040–5046. doi: 10.1016/j.vaccine.2011.04.060.
  • Lanini L.L, Prader S, Siler U, Reichenbach J. Modern management of phagocyte defects. Pediatr Allergy Immunol . 2017;28(2):124–134. doi: 10.1111/pai.12654.
  • Latiff A.H, Kerr M.A. The clinical significance of immunoglobulin a deficiency. Ann Clin Biochem . 2007;44(Pt 2):131–139. doi: 10.1258/000456307780117993.
  • Lee Y.I, Peng C.C, Chiu N.C, Huang D.T, Huang F.Y, Chi H. Risk factors associated with death in patients with severe respiratory syncytial virus infection. J Microbiol Immunol Infect . 2016;49:737–742. doi: 10.1016/j.jmii.2014.08.020.
  • Licastro F, Melotti C, Parente R, et al. Derangement of non-specific immunity in Down syndrome subjects: low leukocyte chemiluminescence activity after phagocytic activation. Am J Med Genet Suppl . 1990;7:242–246. doi: 10.1002/ajmg.1320370749.
  • Lo B, Zhang K, Lu W, et al. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science . 2015;349(6246):436–440. doi: 10.1126/science.aaa1663.
  • Maglione P.J, Simchoni N, Cunningham-Rundles C. Toll-like receptor signaling in primary immune deficiencies. Ann N Y Acad Sci . 2015;1356(1):1–21. doi: 10.1111/nyas.12763.
  • Orange J.S. Natural killer cell deficiency. J Allergy Clin Immunol . 2013;132(3):515–525. doi: 10.1016/j.jaci.2013.07.020.
  • Patuzzo G, Barbieri A, Tinazzi E, et al. Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev . 2016;15(9):877–882. doi: 10.1016/j.autrev.2016.07.011.
  • Picard C, Al-Herz W, Bousfiha A, et al. Primary Immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol . 2015;35(8):696–726. doi: 10.1007/s10875-015-0201-1.
  • Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol . 2011;164(1):9‐16. doi: 10.1111/j.1365-2249.2011.04335.x.
  • Shillitoe B, Gennery A. X-linked agammaglobulinaemia: outcomes in the modern era. Clin Immunol . 2017;183:54–62. doi: 10.1016/j.clim.2017.07.008.
  • Smith CIE, Berglöf A. X-linked agammaglobulinemia. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews®. Seattle, WA: University of Washington, Seattle; 2001.
  • Sokol K, Milner J.D. The overlap between allergy and immunodeficiency. Curr Opin Pediatr . 2018;30(6):848–854. doi: 10.1097/MOP.0000000000000697.
  • Swain S, Selmi C, Gershwin M.E, Teuber S.S. The clinical implications of selective IgA deficiency [published correction appears in J Transl Autoimmun. 2020 Feb 25;3:100041]. J Transl Autoimmun . 2019;2:100025. doi: 10.1016/j.jtauto.2019.100025 Published 2019 Nov 23.
  • Tran T.A. Muckle-Wells syndrome: clinical perspectives. Open Access Rheumatol . 2017;9:123–129. doi: 10.2147/OARRR.S114447 Published 2017 Jul 11.
  • Verbsky J.W, Chatila T.A. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr . 2013;25(6):708–714. doi: 10.1097/MOP.0000000000000029.
  • Walkovich K, Connelly J.A. Congenital neutropenia and rare functional phagocyte disorders in children. Hematol Oncol Clin North Am . 2019;33(3):533–551. doi: 10.1016/j.hoc.2019.01.004.
  • Yu J.E, Orange J.S, Demirdag Y.Y. New primary immunodeficiency diseases: context and future. Curr Opin Pediatr . 2018;30(6):806–820. doi: 10.1097/MOP.0000000000000699.